.gif)
Impax Laboratories, Inc, a specialty pharmaceutical company, has received US Food and Drug Administration (FDA) approval for generic Mestinon Timespan tablets (pyridostigmine bromide extended release), 180 mg. The company is going for commercialisation of this product.
New research suggests that some, but not all adults who have experienced sexual or physical abuse as children go on to develop long term depression, this could partly be due to their specific genetic make up. Researchers also found that the same gene variant that can make a person sad in one context, can trigger happiness in another context. The research was published in the British Journal of Psychiatry Open.
New research shows that a probiotic when given to infants who developed intolerance to cow's milk has reversed the food allergy by increasing gut bacteria. The paper was published in The ISME Journal
Plans of IPWA:
If you are a M.Pharm/Ph.D fresher or experienced, You can not gain value till you don’t have publications and book chapters to your credit. The association is working towards the preparation of pharmacy books/research and review articles
(Theory, Practical, Viva vice, MCQs) of all subjects, viz. Pharmaceutics, NDDS, Pharmaceutical Chemistry, Pharmacology, Quality Assurance, Pharmacy Practice, Drug regulatory affairs, Clinical Research, Pharmacognosy, Microbiology, Biochemistry, Pharmaceutical Management, Biotechnology etc. We need specialists of all the topics, so that the books and articles can be presented as the best possible outcome.
The Drugs Consultative Committee (DCC) is contemplating sale of drugs and medicines by internet in India and for that purpose they constituted a subcommittee to examine risks and apprehensions related to such online sale through internet.
Pfizer’s injectable contraceptive, Sayana®Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for administration by self-injection. This follows the recent approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) of an update to the Sayana® Press label, adding the option for self-injection by women when considered appropriate by a healthcare professional (HCP).
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
Also Join: 
.png)
